Exelixis, Inc. (EXEL)
After hours:
Chart Events
Performance Outlook
| Previous Close | 20.69 |
| Open | 20.46 |
| Bid | 19.49 x 900 |
| Ask | 20.61 x 3200 |
| Day's Range | 19.45 - 20.73 |
| 52 Week Range | 15.50 - 24.75 |
| Volume | |
| Avg. Volume | 2,189,628 |
| Market Cap | 6.167B |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 38.22 |
| EPS (TTM) | 0.51 |
| Earnings Date | Feb 08, 2022 - Feb 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.17 |
- Motley Fool
Can This Cancer Stock Maintain Its Momentum?
The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?
- Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
The stock market is highly volatile now. Robotic-assisted surgery is the future of surgery, and Intuitive Surgical (NASDAQ: ISRG) is already dominating the space. Biotech company Exelixis (NASDAQ: EXEL) and internet retail company Etsy (NASDAQ: ETSY) also have remarkable growth prospects that could bring in some exciting long-term returns.
- Simply Wall St.
Exelixis, Inc. (NASDAQ:EXEL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
With its stock down 11% over the past month, it is easy to disregard Exelixis (NASDAQ:EXEL). But if you pay close...
